Pricing Log in Create free account

Atea Pharmaceuticals, Inc. (AVIR) vs Orchestra BioMed Holdings, Inc. (OBIO)

Atea Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($338.5M and $337.8M). Atea Pharmaceuticals, Inc. has the higher net margin (0.00% vs −186.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Atea Pharmaceuticals, Inc. leads on 10 and Orchestra BioMed Holdings, Inc. on 5.

Valuation

Metric AVIR OBIO Biotechnology median
P/E n/m n/m 10.60
P/S 0.98 11.34 9.40
P/B 1.68 18.76 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.35 8.99 9.02
Earnings yield (48.48%) (17.85%) (32.88%)
Free cash flow yield (160.13%) (16.31%) (23.13%)

Profitability

Metric AVIR OBIO Biotechnology median
Gross margin 0.00% 99.51% 68.51%
Operating margin 0.00% (181.36%) 0.00%
Net margin 0.00% (186.30%) 0.00%
Free cash flow margin 0.00% (184.83%) 0.00%
Return on equity (58.14%) (607.32%) (51.96%)
Return on assets (52.99%) (75.16%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVIR OBIO Biotechnology median
Revenue growth (TTM) — 986.14% 6.76%
EPS growth (last fiscal year) 3.00% 33.13% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVIR OBIO Biotechnology median
Debt to equity 0.00 1.80 0.00
Current ratio 8.13 8.26 4.97
Net debt to EBITDA 1.63 1.80 1.01

Dividend

Metric AVIR OBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AVIR OBIO Biotechnology median
Market cap 338.46m 337.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack